Bertoli, Ada http://orcid.org/0000-0003-0663-2503
Sorbo, Maria Chiara
Aragri, Marianna
Lenci, Ilaria
Teti, Elisabetta
Polilli, Ennio
Di Maio, Velia Chiara
Gianserra, Laura
Biliotti, Elisa
Masetti, Chiara
Magni, Carlo F.
Babudieri, Sergio
Nicolini, Laura A.
Milana, Martina
Cacciatore, Pierluigi
Sarmati, Loredana
Pellicelli, Adriano
Paolucci, Stefania
Craxì, Antonio
Morisco, Filomena
Palitti, Valeria Pace
Siciliano, Massimo
Coppola, Nicola
Iapadre, Nerio
Puoti, Massimo
Rizzardini, Giuliano
Taliani, Gloria
Pasquazzi, Caterina
Andreoni, Massimo
Parruti, Giustino
Angelico, Mario
Perno, Carlo Federico
Cento, Valeria
Ceccherini-Silberstein, Francesca
Andreone, Pietro
Baldanti, Fausto
Barbarini, Giorgio
Boccaccio, Vincenzo
Boglione, Lucio
Bolis, Matteo
Bonora, Stefano
Borghi, Vanni
Brancaccio, Giuseppina
Bruno, Savino
Bruzzone, Bianca
Calvaruso, Vincenza
Caporaso, Nicola
Ciaccio, Antonio
Ciancio, Alessia
Colombatto, Piero
Cozzolongo, Raffaele
D’Ambrosio, Cecilia
D’Ettorre, Gabriella
De Leonardis, Francesco
De Luca, Andrea
Di Biagio, Antonio
Di Perri, Giovanni
Francioso, Simona
Gaeta, Giovanni Battista
Gasbarrini, Antonio
Ghisetti, Valeria
Giorgini, Alessia
Grieco, Antonio
Gubertini, Guido
Gulminetti, Roberto
Lambiase, Lara
Landonio, Simona
Lichtner, Miriam
Maida, Ivana
Marenco, Simona
Marinaro, Letizia
Maserati, Renato
Melis, Michela
Menzaghi, Barbara
Meregalli, Elisa
Micheli, Valeria
Niero, Fosca
Paoloni, Maurizio
Pieri, Alessandro
Rendina, Maria
Romagnoli, Dante
Rossetti, Barbara
Ruggiero, Tina
Sangiovanni, Vincenzo
Starace, Mario
Sticchi, Laura
Tarquini, Pierluigi
Toniutto, Pierluigi
Vullo, Vincenzo
Zazzi, Maurizio
,
Article History
Received: 3 January 2018
Accepted: 16 May 2018
First Online: 12 June 2018
Competing Interests
: Nicola Coppola reports personal fees from AbbVie, Gilead Sciences and Bristol-Myers Squibb. Carlo Federico Perno reports grants from Italian Ministry of Instruction, University and Research (MIUR), and from Aviralia Foundation; personal fees from Gilead Sciences, Abbvie, Roche Diagnostics, Janssen-Cilag, Abbott Molecular; and grants and personal fees from Bristol-Myers Squibb, Merck Sharp & Dohme, and ViiV Healthcare. Valeria Cento reports personal fees from Abbvie, Bristol-1 Myers Squibb, Merck Sharp & Dohme, Janssen-Cilag. Francesca Ceccherini-Silberstein reports personal fees from Gilead Sciences, Bristol-Myers Squibb, Abbvie, Roche Diagnostics, Janssen-Cilag, Abbott Molecular, ViiV Healthcare; grants and personal fees from Merck Sharp & Dohme; grants from Italian Ministry of Instruction, University and Research (MIUR). All other authors have nothing to declare.